Abstract
A set of 56 2-arylbenzimidazoles was designed, synthesized and tested against Leishmania donovani amastigotes. The left- and right-hand side rings of the molecule, as well as the amide linker were modified. Structurally different derivatives were screened on Leishmania donovani axenic amastigotes at concentrations of 5, 15 and 50 mu M, and the ten most active derivatives were selected for further testing. 2-Arylbenzimidazole derivative 24 was active against Leishmania donovani-infected THP-1 cells showing 46% parasite inhibition at 5 mu M. (C) 2015 Elsevier Ltd. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 1933-1937 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 25 |
Issue number | 9 |
DOIs | |
Publication status | Published - 1 May 2015 |
Externally published | Yes |
Publication type | A1 Journal article-refereed |
Funding
This study was supported by the Academy of Finland (projects 264020 and 265481 to J.Y.K.), and the Michael and Penny Feiwel Professorial Chair of Dermatology (C.L.J.).
Keywords
- 2-Arylbenzimidazoles
- Leishmania donovani
- Antileishmanial activity
- Biological activity
- Medicinal chemistry
- CHLAMYDIA-PNEUMONIAE
- AMASTIGOTES
- DERIVATIVES
- INHIBITORS
- ANALOGS
- DESIGN